Amarin Corp plc (ADR)

NASDAQ: AMRN
$4.17
-$0.03 (-0.7%)
Closing price September 18, 2020
Amarin has been right in the middle of this recent market sell-off, and while shares have been halved, the stock could be poised for a strong recovery. All the pieces seem to be there.
Friday's top analyst calls included Amazon, Adobe, AMD, Apple, BlackRock, Broadcom, Caterpillar, Deere, Microsoft, Morgan Stanley, Oracle and Slack.
Shares of Amarin have plunged in recent months. Even more troubling, there appears to no catalyst to drive them higher.
Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce.com, Tesla and Teva Pharmaceutical.
Amarin is a development-stage biotechnology company with one FDA-approved treatment, a cardiovascular disease drug with no real competition. The company looks well-poised to boost sales in 2020 and...
Monday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, Bank of America, Citigroup, Dollar Tree, Nordstrom, Salesforce, Travelers and JD.com.
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of December.
Wednesday's top analyst upgrades, downgrades and initiations include Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, Johnson & Johnson, Replimune, Schlumberger and Transocean.
Monday's top analyst upgrades, downgrades and initiations included Amarin, Bank of America, Citigroup, JPMorgan, Liberty SiriusXM, Microsoft, Tesla, TripAdvisor, Twitter and Workday.
Tuesday's top analyst upgrades, downgrades and initiations included AECOM, Arconic, Bed Bath & Beyond, Dollar General, eBay, Grubhub, Lowe's, Nvidia, Stitch Fix and 3M.
Amarin shares dropped on Friday after the firm announced that it received notice from the FDA that delays a pending supplemental new drug application.
24/7 Wall St. has tracked nine stocks that took big hits in the after-hours trading session on Wednesday, July 17, 2019.
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus analyst price target.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amarin, Apple, AutoNation, BlackRock, E*Trade, Etsy, Kellogg and PG&E.
Amarin shares absolutely skyrocketed on Monday after the company announced topline results from the Vascepa cardiovascular (CV) outcomes trial, REDUCE-IT. Needless to say, the results were very...